Seeking Alpha

RTI Biologics (RTIX): Q4 EPS of $0.04 in-line. Revenue of $44.6M (+4% Y/Y) misses by $0.54M. (PR)

RTI Biologics (RTIX): Q4 EPS of $0.04 in-line. Revenue of $44.6M (+4% Y/Y) misses by $0.54M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)